Table 2.
Genotyped related mortality
|
A-dominant model | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| G-286Aars3087456 |
G-712Aars12596540 |
|||||||||
| AA or AG (n = 176) | GG (n = 27) | OR | 95% CI | P Valuea | AA or AG (n = 189) | GG (n = 14) | OR | 95% CI | P Valuea | |
| 28-daymortality, n (%) | 62 (35.2) | 15 (55.6) | 2.298 | 1.013-5.217 | 0.043 | 69 (36.5) | 8 (57.1) | 2.319 | 0.773-6.960 | 0.13 |
| 7-day mortality, n (%) | 46 (50) | 10 (37) | 1.662 | 0.710-3.891 | 0.24 | 49 (25.9) | 7 (50) | 2.857 | 0.954-8.558 | 0.05 |
| Secondary infections, n (%) | 39 (20.7) | 4 (14.8) | 0.611 | 0.199-1.872 | 0.38 | 41 (21.7) | 2 (14.3) | 0.602 | 0.129-2.796 | 0.49 |
|
Co-dominant model | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| G-286Aars3087456 |
G-712Aars12596540 |
|||||||||
| AA (n = 92) | AG (n = 84) | GG (n = 27) | All (n = 203) | P Valuea | AA (n = 113) | AG (n = 76) | GG (n = 14) | All (n = 203) | P Valuea | |
| 28-day mortality, n (%) | 35 (38) | 27 (32.1) | 15 (55.6) | 77 (37.9) | 0.10 | 45 (39.8) | 24 (31.6) | 8 (57.1) | 77 (37.9) | 0.16 |
| 7-day mortality, n (%) | 25 (27.2) | 21 (25) | 10 (37) | 56 (27.6) | 0.47 | 31 (27.2) | 18 (23.7) | 7 (50) | 56 (27.6) | 0.13 |
| Secondary infections, n (%) | 19 (20.7) | 20 (23.8) | 4 (14.8) | 43 (21.2) | 0.61 | 23 (20.3) | 18 (23.7) | 2 (14.3) | 43 (21.2) | 0.70 |
a
p values were calculated with the use of chi-square test and Kruskal-Wallis test.